Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Syprine
2. Trien
3. Trientine
4. Trientine Dihydrochloride
5. Triethylenetetramine
1. Triethylenetetramine Dihydrochloride
2. 38260-01-4
3. Syprine
4. Trientine Dihydrochloride
5. Trientine Hcl
6. Mk-0681
7. 1,2-ethanediamine, N,n'-bis(2-aminoethyl)-, Dihydrochloride
8. Triethylene Tetramine Dihydrochloride
9. Teta
10. N,n'-bis(2-aminoethyl)-1,2-ethanediamine Dihydrochloride
11. Hc3nx54582
12. Nsc-759164
13. N1,n1'-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Dihydrochloride
14. Trien Dihydrochloride
15. Cuprid
16. 1,2-ethanediamine,n1,n2-bis(2-aminoethyl)-, Hydrochloride (1:2)
17. Trientine Hydrochloride [usan]
18. Einecs 253-854-3
19. Mk 0681
20. N,n'-bis(2-aminoethyl)ethylenediamine Dihydrochloride
21. Laszarin
22. Metalite
23. Unii-hc3nx54582
24. Trientine-2hcl
25. 2,2'-ethylenediiminobis(ethylamine) Dihydrochloride
26. Syprine (tn)
27. Trientine Hydrochloride [usan:usp]
28. Trientinedihydrochloride
29. Triethyl Enetetramine 2hcl
30. Schembl506189
31. Chebi:9706
32. Chembl3989777
33. Dtxsid2057863
34. Amy3335
35. Tja-250
36. Mk-681
37. N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride
38. S6585
39. Trientine Hydrochloride (jp17/usp)
40. Trientine Hydrochloride [jan]
41. Trientine Dihydrochloride [mi]
42. Akos028109579
43. Ccg-213505
44. Nsc 759164
45. Trientine Hydrochloride [vandf]
46. Trientine Hydrochloride [usp-rs]
47. Trientine Dihydrochloride [mart.]
48. Bs-49370
49. Trientine Dihydrochloride [who-dd]
50. Db-049259
51. Ft-0639448
52. Trientine Hydrochloride [orange Book]
53. D00736
54. E78246
55. Trientine Hydrochloride [usp Monograph]
56. 260t014
57. Q27279855
58. N1,n1'-(ethane-1,2-diyl)diethane-1,2-diamine Dihydrochloride
59. N\'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,dihydrochloride
60. Trientine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
61. Triethylenetetramine Dihydrochloride, Puriss., 2xcryst., >=99.0% (at)
62. Trientine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 219.15 g/mol |
|---|---|
| Molecular Formula | C6H20Cl2N4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 218.1065020 g/mol |
| Monoisotopic Mass | 218.1065020 g/mol |
| Topological Polar Surface Area | 76.1 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 49.7 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Syprine |
| PubMed Health | Trientine (By mouth) |
| Drug Classes | Heavy Metal Chelator |
| Drug Label | Trientine hydrochloride is N,N'-bis (2-aminoethyl)-1,2-ethanediamine dihydrochloride. It is a white to pale yellow crystalline hygroscopic powder. It is freely soluble in water, soluble in methanol, slightly soluble in ethanol, and insoluble in chlor |
| Active Ingredient | Trientine hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 250mg |
| Market Status | Prescription |
| Company | Aton |
| 2 of 2 | |
|---|---|
| Drug Name | Syprine |
| PubMed Health | Trientine (By mouth) |
| Drug Classes | Heavy Metal Chelator |
| Drug Label | Trientine hydrochloride is N,N'-bis (2-aminoethyl)-1,2-ethanediamine dihydrochloride. It is a white to pale yellow crystalline hygroscopic powder. It is freely soluble in water, soluble in methanol, slightly soluble in ethanol, and insoluble in chlor |
| Active Ingredient | Trientine hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 250mg |
| Market Status | Prescription |
| Company | Aton |
Cufence is indicated for the treatment of Wilsons disease in patients intolerant to D-Penicillamine therapy, in adults and children aged 5 years or older.
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
A16A
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-23
Pay. Date : 2016-09-13
DMF Number : 30878
Submission : 2016-11-08
Status : Active
Type : II
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm :
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-03-01
Pay. Date : 2015-09-15
DMF Number : 29527
Submission : 2015-09-03
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-01-21
Pay. Date : 2014-05-07
DMF Number : 12659
Submission : 1997-09-18
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-03
Pay. Date : 2018-07-17
DMF Number : 32956
Submission : 2018-07-19
Status : Active
Type : II
Date of Issue : 2022-08-16
Valid Till : 2025-07-15
Written Confirmation Number : WC-0042N
Address of the Firm :

GDUFA
DMF Review : Reviewed
Rev. Date : 2017-09-14
Pay. Date : 2017-08-17
DMF Number : 31085
Submission : 2016-12-02
Status : Active
Type : II
Date of Issue : 2023-04-06
Valid Till : 2026-05-19
Written Confirmation Number : WC-0281
Address of the Firm :
NDC Package Code : 50379-0025
Start Marketing Date : 2023-03-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2020-10-23
Pay. Date : 2020-06-19
DMF Number : 34910
Submission : 2020-08-28
Status : Active
Type : II
NDC Package Code : 70966-0016
Start Marketing Date : 1985-11-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 50379-0017
Start Marketing Date : 2015-10-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Complete
Rev. Date : 2016-12-23
Pay. Date : 2016-09-13
DMF Number : 30878
Submission : 2016-11-08
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-01
Pay. Date : 2015-09-15
DMF Number : 29527
Submission : 2015-09-03
Status : Active
Type : II
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-21
Pay. Date : 2014-05-07
DMF Number : 12659
Submission : 1997-09-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-18
Pay. Date : 2015-04-13
DMF Number : 29085
Submission : 2015-08-27
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2017-03-17
Pay. Date : 2016-09-14
DMF Number : 30905
Submission : 2016-09-15
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2017-04-17
Pay. Date : 2017-02-22
DMF Number : 31395
Submission : 2017-02-23
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2017-09-14
Pay. Date : 2017-08-17
DMF Number : 31085
Submission : 2016-12-02
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5351
Submission : 1984-05-17
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2018-09-03
Pay. Date : 2018-07-17
DMF Number : 32956
Submission : 2018-07-19
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32113
Submission : 2017-12-13
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Japanese Pharmacopoeia Trientine Hydrochloride
Registration Number : 218MF10740
Registrant's Address : 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Initial Date of Registration : 2006-09-06
Latest Date of Registration : 2006-09-06

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm : Plot No. 111, SIDCO Industrial Estate, Kakkalur, Thiruvallur 602 003, Tamil Nadu...
Date of Issue : 2026-03-16
Valid Till : 2029-03-16
Written Confirmation Number : WC-0369
Address of the Firm : Plot No. 1134, 1135, 1136, 1137,1143B, 1144 A&B, 1138 A&B, Padra -Jambusar Highw...

Date of Issue : 2022-09-30
Valid Till : 2025-09-08
Written Confirmation Number : WC-0369n
Address of the Firm : Plot No 1134, 1135, 1136, 1137, 1143B, 1144 A & B, 1138 A & B, Padra Jambusar Hi...

Date of Issue : 2023-11-15
Valid Till : 2026-11-14
Written Confirmation Number : WC-0404
Address of the Firm : Plot No. 40/A, Sy Nos. 13,15,16,51,52 & 182, J.N. Pharma city, Thanam Village, P...

Date of Issue : 2025-09-26
Valid Till : 2028-07-02
Written Confirmation Number : WC-0226
Address of the Firm : D-24 & D-24/1, M.I.D.C., Kurkumbh, Taluka: Daund, District. Pune -413802, Mahara...

Trientine Hydrochloride USP/Ph.Eur
Date of Issue : 2023-04-06
Valid Till : 2026-05-19
Written Confirmation Number : WC-0281
Address of the Firm : Sy.No.224/A, Bibinagar (V&M), Yadadri Bhuvanagiri (Dist), Telangana State, Pinco...

Date of Issue : 2022-08-16
Valid Till : 2025-07-15
Written Confirmation Number : WC-0042N
Address of the Firm : Plot Nos. 262 to 271, IDA, Pashamylaram, Sangareddy District- 502 307, Telangana...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 76339-133
Start Marketing Date : 2019-09-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (9.999kg/9.999kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 69575-4003
Start Marketing Date : 2015-11-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 70966-0016
Start Marketing Date : 1985-11-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14593-914
Start Marketing Date : 2023-09-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 50379-0025
Start Marketing Date : 2023-03-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 50379-0017
Start Marketing Date : 2015-10-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 59285-026
Start Marketing Date : 2019-12-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 65392-2901
Start Marketing Date : 1985-11-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
About the Company : Nuray Chemicals Pvt Ltd, established in 2012 near Chennai, is an API manufacturer for highly regulated markets. Its state-of-the-art R&D facility specializes in synthesizing NCEs, ...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform delivering products and services across the full molecule lifecycle, from development to commercialization. With strong expe...
About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...
About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities...
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
About the Company : Curia is a leading global CDMO with over 30 years of experience supporting clients across drug discovery, development, and commercial manufacturing. Leveraging deep scientific expe...
About the Company : Apino Pharma prides itself on being an innovation-driven company that strives to continuously improve its products and services. Our dedicated innovation team collaborates with the...

About the Company : Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non Govt Company. This c...

About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...

About the Company : SKVEN Technologies is a diverse pharmaceutical company that is committed to focusing on our customers while delivering consistently high performance. Our Vision, Mission and in Val...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-07-03
Application Number : 211076
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2018-02-07
Application Number : 207567
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-02-08
Application Number : 210619
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : SYPRINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1985-11-08
Application Number : 19194
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-09-16
Application Number : 209415
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CLOVIQUE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-10-21
Application Number : 209731
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2021-08-13
Application Number : 209945
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-05-22
Application Number : 211134
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-01-16
Application Number : 211251
Regulatory Info : RX
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-07-03
Application Number : 211076
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2021-08-30
Application Number : 212929
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2018-02-07
Application Number : 207567
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Brand Name : SYPRINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 1985-11-08
Application Number : 19194
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-09-16
Application Number : 209415
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CLOVIQUE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-10-21
Application Number : 209731
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2020-05-21
Application Number : 211637
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2019-01-16
Application Number : 211251
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Approval Date : 2020-02-20
Application Number : 212238
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 500MG
Approval Date : 2023-09-22
Application Number : 212238
RX/OTC/DISCN : RX
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
85
PharmaCompass offers a list of Trientine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Trientine Hydrochloride manufacturer or Trientine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trientine Hydrochloride manufacturer or Trientine Hydrochloride supplier.
A Trientine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trientine Dihydrochloride, including repackagers and relabelers. The FDA regulates Trientine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trientine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trientine Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Trientine Dihydrochloride supplier is an individual or a company that provides Trientine Dihydrochloride active pharmaceutical ingredient (API) or Trientine Dihydrochloride finished formulations upon request. The Trientine Dihydrochloride suppliers may include Trientine Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trientine Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Trientine Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trientine Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trientine Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Trientine Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trientine Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trientine Dihydrochloride USDMF includes data on Trientine Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trientine Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trientine Dihydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trientine Dihydrochloride Drug Master File in Japan (Trientine Dihydrochloride JDMF) empowers Trientine Dihydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trientine Dihydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Trientine Dihydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trientine Dihydrochloride suppliers with JDMF on PharmaCompass.
A Trientine Dihydrochloride written confirmation (Trientine Dihydrochloride WC) is an official document issued by a regulatory agency to a Trientine Dihydrochloride manufacturer, verifying that the manufacturing facility of a Trientine Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trientine Dihydrochloride APIs or Trientine Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Trientine Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Trientine Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trientine Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trientine Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trientine Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trientine Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trientine Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trientine Dihydrochloride suppliers with NDC on PharmaCompass.
Trientine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trientine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Trientine Dihydrochloride GMP manufacturer or Trientine Dihydrochloride GMP API supplier for your needs.
A Trientine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trientine Dihydrochloride's compliance with Trientine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Trientine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trientine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trientine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trientine Dihydrochloride EP), Trientine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trientine Dihydrochloride USP).